Platelet‐rich plasma provides modest but durable functional benefit over corticosteroid for rotator cuff tendinopathy: A systematic review and meta‐analysis of randomized controlled trials
Knee Surgery, Sports Traumatology, Arthroscopy · 2026-08 · 34 (8) · 2937-2950
DOI: 10.1002/ksa.70416 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Knee Surgery, Sports Traumatology, Arthroscopy, online erschienen am 23.04.2026. Verfasst von Chulayut Yuwarungsikul und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sports Medicine Research Group, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Rotator Cuff Injuries, Adrenal Cortex Hormones, Tendinopathy. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
To compare platelet‐rich plasma (PRP) and corticosteroid (CS) injections in rotator cuff tendinopathy and partial‐thickness tears.
Methods
A systematic review was conducted. Eligible studies were randomized controlled trials (RCTs) of adults (≥18 years) with rotator cuff tendinopathy or partial tears comparing PRP with CS injections. Primary outcomes were pain, patient‐reported outcome scores and adverse events. Random‐effects meta‐analyses were performed using mean difference (MD) or risk ratio (RR) with 95% confidence intervals (CIs).
Results
Ten RCTs ( n = 591) were included. At 3‐ to 6‐week and 3‐month follow‐up, pain and patient‐reported outcomes did not differ significantly between groups. At 6 months, PRP demonstrated clearer benefits. PRP improved American Shoulder and Elbow Surgeons score (ASES) (MD + 10.8, 95% CI: 4.71–16.80, p = 0.0005) and Constant–Murley score (CMS) (MD + 10.7, 95% CI: 1.21–20.27, p = 0.027). Pain reduction at 6 months favoured PRP (pain visual analogue scale [VAS] MD −0.8, 95% CI: −1.45 to −0.18, p = 0.012). PRP was associated with fewer adverse events (RR 0.66, 95% CI: 0.44–0.99, p = 0.047).
Conclusions
PRP injections offer statistically significant, although clinically modest, improvements in pain and shoulder function compared with CS injections and are associated with fewer adverse events at 6 months. Taken together, these findings suggest that PRP may serve as a more durable treatment option for patients with rotator cuff tendinopathy. Level of Evidence Level I.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sports Medicine Research Group, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Department of Anatomy, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Department of Orthopaedics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
ORCID-Profile: Napatpong Thamrongskulsiri, Danaithep Limskul, Somsak Kuptniratsaikul, Thun Itthipanichpong
Zitieren
APA
Yuwarungsikul, C., Phisalaphong, K., Thamrongskulsiri, N., Limskul, D., Tanpowpong, T., Kuptniratsaikul, S., & Itthipanichpong, T. (2026). Platelet‐rich plasma provides modest but durable functional benefit over corticosteroid for rotator cuff tendinopathy: A systematic review and meta‐analysis of randomized controlled trials. Knee Surgery, Sports Traumatology, Arthroscopy, 34(8), 2937-2950. https://doi.org/10.1002/ksa.70416
Vancouver
Yuwarungsikul C, Phisalaphong K, Thamrongskulsiri N, Limskul D, Tanpowpong T, Kuptniratsaikul S, et al. Platelet‐rich plasma provides modest but durable functional benefit over corticosteroid for rotator cuff tendinopathy: A systematic review and meta‐analysis of randomized controlled trials. Knee Surgery, Sports Traumatology, Arthroscopy. 2026;34(8):2937-2950. doi:10.1002/ksa.70416
BibTeX
@article{Yuwarungsikul2026,
author = {Yuwarungsikul, Chulayut and Phisalaphong, Krit and Thamrongskulsiri, Napatpong and Limskul, Danaithep and Tanpowpong, Thanathep and Kuptniratsaikul, Somsak and Itthipanichpong, Thun},
title = {Platelet‐rich plasma provides modest but durable functional benefit over corticosteroid for rotator cuff tendinopathy: A systematic review and meta‐analysis of randomized controlled trials},
journal = {Knee Surgery, Sports Traumatology, Arthroscopy},
year = {2026},
volume = {34},
number = {8},
pages = {2937--2950},
doi = {10.1002/ksa.70416}
}
EUVIMED